Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Marcello Govoni

Showing results (231-240 of 254) with videos related to

Pageof 26
Sort By:
RMD Open|December 6, 2023
Still's disease continuum from childhood to elderly: data from the international AIDA Network Still's disease registryAntonio Vitale, Valeria Caggiano, Giuseppe Lopalco, et al.
Seminars in Arthritis and Rheumatism|July 30, 2023
The administration of methotrexate in patients with Still's disease, "real-life" findings from AIDA Network Still Disease RegistryPiero Ruscitti, Jurgen Sota, Antonio Vitale, et al.
RMD Open|May 13, 2026
Clinical and serological features of triple autoantibody-negative patients with systemic sclerosis: insights from the multicentric SPRING registry of the Italian Society for RheumatologyVeronica Batani, Ilaria Cavazzana, Martina Orlandi, et al.
Arthritis Care & Research|December 30, 2025
MYCOPHENOLATE MOFETIL TREATMENT REDUCES THE RISK OF TREATMENT ESCALATION DUE TO VASCULAR COMPLICATIONS IN LIMITED CUTANEOUS SYSTEMIC SCLEROSIS: EMULATION OF A TARGET TRIAL FROM ITALIAN RHEUMATOLOGY SOCIETY SPRING REGISTRYEnrico De Lorenzis, Gerlando Natalello, Rossella De Angelis, et al.
Arthritis & Rheumatology (Hoboken, N.J.)|March 19, 2024
The Systemic Score May Identify Life-Threatening Evolution in Still Disease: Data from the GIRRCS AOSD-Study Group and the AIDA Network Still Disease RegistryPiero Ruscitti, Francesco Masedu, Antonio Vitale, et al.
The Journal of Rheumatology|November 15, 2024
Evaluation of Myocarditis in Patients With Still Disease: Clinical Findings From the Multicenter International AIDA Network Still Disease RegistryPiero Ruscitti, Ilenia Di Cola, Antonio Vitale, et al.
Internal and Emergency Medicine|October 12, 2023
Clinical and laboratory features associated with macrophage activation syndrome in Still's disease: data from the international AIDA Network Still's Disease RegistryPaola Triggianese, Antonio Vitale, Giuseppe Lopalco, et al.
Internal and Emergency Medicine|December 27, 2023
Correction: Clinical and laboratory features associated with macrophage activation syndrome in Still's disease: data from the international AIDA Network Still's Disease RegistryPaola Triggianese, Antonio Vitale, Giuseppe Lopalco, et al.
Frontiers in Medicine|August 14, 2025
Predictors of uveitic macular edema and functional prognostic outcomes: real-life data from the international AIDA Network uveitis registryJurgen Sota, Germán Mejía-Salgado, Silvana Guerriero, et al.
Ocular Immunology and Inflammation|May 17, 2024
Impact of HLA-B51 on Uveitis and Retinal Vasculitis: Data from the AIDA International Network Registries on Ocular Inflammatory DisordersJurgen Sota, Silvana Guerriero, Giuseppe Lopalco, et al.
Pageof 26

Showing results (231-240 of 254) with videos related to

Sort By:
Pageof 26
RMD Open|December 6, 2023
Still's disease continuum from childhood to elderly: data from the international AIDA Network Still's disease registryAntonio Vitale, Valeria Caggiano, Giuseppe Lopalco, et al.
Seminars in Arthritis and Rheumatism|July 30, 2023
The administration of methotrexate in patients with Still's disease, "real-life" findings from AIDA Network Still Disease RegistryPiero Ruscitti, Jurgen Sota, Antonio Vitale, et al.
RMD Open|May 13, 2026
Clinical and serological features of triple autoantibody-negative patients with systemic sclerosis: insights from the multicentric SPRING registry of the Italian Society for RheumatologyVeronica Batani, Ilaria Cavazzana, Martina Orlandi, et al.
Arthritis Care & Research|December 30, 2025
MYCOPHENOLATE MOFETIL TREATMENT REDUCES THE RISK OF TREATMENT ESCALATION DUE TO VASCULAR COMPLICATIONS IN LIMITED CUTANEOUS SYSTEMIC SCLEROSIS: EMULATION OF A TARGET TRIAL FROM ITALIAN RHEUMATOLOGY SOCIETY SPRING REGISTRYEnrico De Lorenzis, Gerlando Natalello, Rossella De Angelis, et al.
Arthritis & Rheumatology (Hoboken, N.J.)|March 19, 2024
The Systemic Score May Identify Life-Threatening Evolution in Still Disease: Data from the GIRRCS AOSD-Study Group and the AIDA Network Still Disease RegistryPiero Ruscitti, Francesco Masedu, Antonio Vitale, et al.
The Journal of Rheumatology|November 15, 2024
Evaluation of Myocarditis in Patients With Still Disease: Clinical Findings From the Multicenter International AIDA Network Still Disease RegistryPiero Ruscitti, Ilenia Di Cola, Antonio Vitale, et al.
Internal and Emergency Medicine|October 12, 2023
Clinical and laboratory features associated with macrophage activation syndrome in Still's disease: data from the international AIDA Network Still's Disease RegistryPaola Triggianese, Antonio Vitale, Giuseppe Lopalco, et al.
Internal and Emergency Medicine|December 27, 2023
Correction: Clinical and laboratory features associated with macrophage activation syndrome in Still's disease: data from the international AIDA Network Still's Disease RegistryPaola Triggianese, Antonio Vitale, Giuseppe Lopalco, et al.
Frontiers in Medicine|August 14, 2025
Predictors of uveitic macular edema and functional prognostic outcomes: real-life data from the international AIDA Network uveitis registryJurgen Sota, Germán Mejía-Salgado, Silvana Guerriero, et al.
Ocular Immunology and Inflammation|May 17, 2024
Impact of HLA-B51 on Uveitis and Retinal Vasculitis: Data from the AIDA International Network Registries on Ocular Inflammatory DisordersJurgen Sota, Silvana Guerriero, Giuseppe Lopalco, et al.
Pageof 26